- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00812422
The Efficacy and Safety of Dexibuprofen Syrup
January 15, 2010 updated by: Inje University
Multi-center, Randomized, Double Blinded (Double-dummy), Active-Controlled Parallel-group Comparative, Phase 3 Clinical Trial to Assess the Efficacy and Safety of Dexibuprofen Syrup Compared to Ibuprofen Syrup in Patients With Fever of Common Cold (Acute Upper Respiratory Infection)
The purpose of this study is to compare the safety and efficacy of dexibuprofen syrup and ibuprofen syrup in patients with fever due to common cold.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
260
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Asan Medical Center
-
Seoul, Korea, Republic of
- Korea University Hospital
-
Seoul, Korea, Republic of
- Kyung Hee University Hospital
-
Seoul, Korea, Republic of
- Inje University Sanggye Paik Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 months to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Common cold with fever
- Age 6 months to 14 years
Exclusion Criteria:
- Gastric ulcer
- Bleeding tendency
- Liver disease
- Kidney disease
- Hypertension
- Hypersensitivity to the drug
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dexibuprofen 1
Dexibuprofen 2.5 or 5 mg/kg
|
one dose of Dexibuprofen 2.5 or 5 mg/kg
one dose of Dexibuprofen 3.5 or 7 mg/kg
|
Experimental: Dexibuprofen 2
Dexibuprofen 3.5 or 7 mg/kg
|
one dose of Dexibuprofen 2.5 or 5 mg/kg
one dose of Dexibuprofen 3.5 or 7 mg/kg
|
Active Comparator: Ibuprofen
Ibuprofen 5 or 10 mg/kg
|
one dose of Ibuprofen 5 or 10 mg/kg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
measure reduction in fever
Time Frame: measure temperature every hour for 3 hours then once again 3 days later
|
measure temperature every hour for 3 hours then once again 3 days later
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
determine safety of dexibuprofen by unwanted reaction, clinical laboratory test and physical examination.
Time Frame: every hour for 3 hours (unwanted reaction). 3 days later (clinical laboratory test and physical examination).
|
every hour for 3 hours (unwanted reaction). 3 days later (clinical laboratory test and physical examination).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Young Yull Koh, Seoul National University Hospital
- Principal Investigator: Chang-Keun Kim, Inje University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
December 19, 2008
First Submitted That Met QC Criteria
December 19, 2008
First Posted (Estimate)
December 22, 2008
Study Record Updates
Last Update Posted (Estimate)
January 18, 2010
Last Update Submitted That Met QC Criteria
January 15, 2010
Last Verified
January 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Body Temperature Changes
- Infections
- Fever
- Respiratory Tract Infections
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Ibuprofen
Other Study ID Numbers
- AG_DIBU_2007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fever
-
Meir Medical CenterCompleted
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
U.S. Army Medical Research and Development CommandBausch Health Americas, Inc.WithdrawnCrimean-Congo Hemorrhagic Fever | Lassa FeverGermany
-
The Scientific and Technological Research Council...MonitorCROCompleted
-
Sanofi Pasteur, a Sanofi CompanyUnited States Department of DefenseCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
Tongji HospitalRecruitingHFRS (Hemorrhagic Fever With Renal Syndrome)China
-
Shaare Zedek Medical CenterCompleted
-
Carina Mari ApariciWithdrawnFever of Unknown OriginUnited States
-
University Hospital, GrenobleCompletedFever of Unknown OriginFrance
Clinical Trials on Dexibuprofen
-
Apsen Farmaceutica S.A.CompletedHealthy VolunteersBrazil
-
Apsen Farmaceutica S.A.CompletedHealthy VolunteersBrazil
-
Gebro Pharma GmbHCompletedOsteoarthritis of the Hip or KneeAustria
-
University of Southern DenmarkOdense University Hospital; Region Syddanmark; Association of Danish Physiotherapists and other collaboratorsCompleted